News | Artificial Intelligence | June 13, 2018

Platform provides access to over 53 artificial intelligence engines that may be applied to medical imaging studies

Wake Radiology Launches First Installation of EnvoyAI Platform

June 13, 2018 — Artificial intelligence (AI) platform provider EnvoyAI recently completed their first successful customer installation at Wake Radiology in Raleigh, N.C. Wake Radiology is using the platform to provide physicians access to EnvoyAI’s growing marketplace of over 53 AI engines that may be applied to their medical imaging studies. Wake Radiology selected EnvoyAI as the fastest and most comprehensive means to achieving a complete AI strategy for the diverse breadth of clinical services that it provides for patients and referring physicians.

With nearly 50 radiologists, Wake Radiology is now able to experiment with scores of new technologies and has already brought five of the imaging processing engines to pre-production status, with reportedly excellent performance and results. “We realize that AI has great potential to improve healthcare by increasing our efficiency and efficacy as providers. It is important that we embrace the technology early to maximize its effect in our practice and in the lives of our patients. Implementing EnvoyAI gives our physicians an easy and integrated way to begin interacting with the wide variety of algorithms available on the EnvoyAI Exchange from directly within the PACS [picture archiving and communication system] environment. Our radiologists can experiment and immediately apply algorithms that impact their workflow and patient care.” shared Chief Medical Officer William Way, M.D., of Wake Radiology.  

Wake Radiology Chief Information Officer Matt Dewey said, “Wake Radiology has very stringent security requirements. What would have otherwise been a multitude of unacceptable implementation and security challenges resulting from purchasing algorithms separately, has been simplified into a single turn-key platform. We were very impressed with the depth of thought and creativity that went into designing the EnvoyAI security and workflow features. The implementation was seamless and the technical support has been fantastic.”

EnvoyAI said that this initial commercial implementation will be followed quickly by many others around the U.S., which are already underway.  

The company demonstrated the EnvoyAI platform at the Society for Imaging Informatics in Medicine (SIIM) annual meeting, May 31-June 2 in National Harbor, Md.

For more information: www.envoyai.com


Related Content

News | Radiopharmaceuticals and Tracers

May 27, 2026 — Subtle Medical has received FDA clearance for its SubtleHD (PET), the company's next-generation AI ...

Time May 27, 2026
arrow
News | FDA

May 19, 2026 — DeepHealth has received the CE Mark for the Brain Health and Brain Age solutions within its Neuro Suite ...

Time May 26, 2026
arrow
News | Cardiac Imaging

May 21, 2026 — A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s ...

Time May 22, 2026
arrow
News | X-Ray

May 21, 2026 — RADIN Health and AZmed have announced the expansion of their strategic partnership and enhance radiology ...

Time May 22, 2026
arrow
News | Digital Pathology

May 7, 2026 — Roche has entered into a definitive merger agreement to acquire PathAI, a U.S.-based company in digital ...

Time May 21, 2026
arrow
News | Computed Tomography (CT)

May 12, 2026 – Bracco Imaging S.p.A. has purchased a mobile photon-counting CT scanner from MARS Bioimaging to support ...

Time May 20, 2026
arrow
Feature | Enterprise Imaging | Kyle Hardner

For radiology departments, the imbalance between surging imaging volume and a shortage of trained radiologists is taking ...

Time May 20, 2026
arrow
News | Interventional Radiology

May 12, 2026 — Siemens Healthineers has received clearance from the Food and Drug Administration for six new systems in ...

Time May 12, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

May 11, 2026 – At the International Society for Magnetic Resonance in Medicine (ISMRM) 2026 Annual Meeting, GE ...

Time May 11, 2026
arrow
News | FDA

May 6, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 07, 2026
arrow
Subscribe Now